Intuitive Surgical (NASDAQ:ISRG – Get Free Report) is projected to post its Q3 2025 results after the market closes on Tuesday, October 21st. Analysts expect Intuitive Surgical to post earnings of $2.00 per share and revenue of $2.4075 billion for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 21, 2025 at 4:30 PM ET.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.78 earnings per share. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Intuitive Surgical Price Performance
NASDAQ:ISRG opened at $446.13 on Friday. The firm has a market capitalization of $159.93 billion, a PE ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The business’s fifty day moving average price is $454.97 and its 200 day moving average price is $495.75. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00.
Analyst Ratings Changes
Check Out Our Latest Analysis on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
Hedge funds have recently made changes to their positions in the business. Riggs Asset Managment Co. Inc. boosted its stake in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the period. Osterweis Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $200,000. Darwin Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $218,000. Security National Bank of SO Dak acquired a new stake in Intuitive Surgical in the second quarter valued at about $220,000. Finally, Blue Chip Partners LLC acquired a new stake in Intuitive Surgical in the second quarter valued at about $237,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Following Congress Stock Trades
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- High Flyers: 3 Natural Gas Stocks for March 2022
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Using the MarketBeat Dividend Tax Calculator
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.